Diagnostics Overview

Migration, Crosslink

📖

Diagnostics Overview

active

wiki page Created: 2026-04-02T07:20:09 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diagnostics-overview

📖 Wiki Page

diagnostic1133 wordssynced 2026-04-02

Diagnostic Methods Overview

Introduction

Accurate diagnosis of neurodegenerative diseases requires a multimodal approach combining clinical assessment, biomarker analysis, neuroimaging, and increasingly, digital health technologies. This overview provides a comprehensive guide to the diagnostic landscape for Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other related conditions. [@biomarkers2023]

The diagnostic paradigm has shifted dramatically in recent years, moving from purely clinical diagnosis toward biomarker-confirmed detection that can identify pathology even before clinical symptoms emerge [1](https://doi.org/10.1016/S1474-4422(23)00408-4). [@moca2005]

Diagnostic Modalities

Clinical Assessment

Clinical evaluation remains the cornerstone of neurodegenerative disease diagnosis. Neurologists and geriatricians assess: [@updrs2003]

Cognitive Function: Memory, executive function, language, visuospatial abilities
Motor Function: Tremor, rigidity, bradykinesia, gait disturbances
Behavioral Changes: Apathy, disinhibition, sleep disorders
Functional Independence: Ability to perform activities of daily living

...

Diagnostic Methods Overview

Introduction

Accurate diagnosis of neurodegenerative diseases requires a multimodal approach combining clinical assessment, biomarker analysis, neuroimaging, and increasingly, digital health technologies. This overview provides a comprehensive guide to the diagnostic landscape for Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other related conditions. [@biomarkers2023]

The diagnostic paradigm has shifted dramatically in recent years, moving from purely clinical diagnosis toward biomarker-confirmed detection that can identify pathology even before clinical symptoms emerge [1](https://doi.org/10.1016/S1474-4422(23)00408-4). [@moca2005]

Diagnostic Modalities

Clinical Assessment

Clinical evaluation remains the cornerstone of neurodegenerative disease diagnosis. Neurologists and geriatricians assess: [@updrs2003]

Cognitive Function: Memory, executive function, language, visuospatial abilities
Motor Function: Tremor, rigidity, bradykinesia, gait disturbances
Behavioral Changes: Apathy, disinhibition, sleep disorders
Functional Independence: Ability to perform activities of daily living

Standardized scales include the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA) for cognition [2](https://pubmed.ncbi.nlm.nih.gov/15954109/), Unified Parkinson's Disease Rating Scale (UPDRS) for PD [3](https://pubmed.ncbi.nlm.nih.gov/11136110/), and Clinical Dementia Rating (CDR) for dementia staging [4](https://pubmed.ncbi.nlm.nih.gov/8187591/). [@clinical1982]

Neuroimaging

Neuroimaging provides crucial information about brain structure and function: [@hippocampal2002]

Structural MRI: [@datspect2014]

Assesses regional brain atrophy patterns
Rules out treatable causes of dementia
Differentiates between AD, FTD, vascular dementia
Hippocampal atrophy is a key AD biomarker [5](https://pubmed.ncbi.nlm.nih.gov/11806130/)

PET Imaging: [@atn2018]

Amyloid PET (florbetapir, flutemetamol, florbetaben) detects amyloid plaques
[Tau](/proteins/tau) PET (flortaucipir) visualizes neurofibrillary tangles
FDG-PET shows hypometabolism patterns specific to each disease
Dopamine transporter SPECT (DaT-SPECT) confirms dopaminergic deficit in PD [6](https://pubmed.ncbi.nlm.nih.gov/24366148/)

Advanced Techniques: [@apoe2010]

Diffusion tensor imaging (DTI) reveals white matter integrity
Functional MRI (fMRI) measures connectivity changes
MR spectroscopy detects metabolic alterations

Fluid Biomarkers

Cerebrospinal fluid (CSF) and blood-based biomarkers provide molecular insights:

Alzheimer's Disease:

[Amyloid-beta](/proteins/amyloid-beta) 42/40 ratio (decreased in AD)
Total tau (elevated in AD)
Phosphorylated tau (elevated in AD)
The AT(N) classification system standardizes biomarker interpretation [7](https://doi.org/10.1016/j.jalz.2018.02.013)

Parkinson's Disease:

[Neurofilament light](/biomarkers/neurofilament-light-chain-nfl) chain (NfL) - marker of neurodegeneration
[Alpha-synuclein](/proteins/alpha-synuclein) seeding assays (RT-QuIC, PMCA)
Urate (protective association)

ALS:

Neurofilament light chain (NfL) and phosphorylated heavy chain (pNfH)
Prognostic and disease progression markers

Genetic Testing

Genetic analysis identifies risk factors and confirms monogenic forms:

[APOE](/proteins/apoe) genotyping: E4 allele increases AD risk 3-4 fold [8](https://pubmed.ncbi.nlm.nih.gov/19968377/)
Monogenic testing: [APP](/entities/app-protein), [PSEN1](/entities/psen1), [PSEN2](/entities/psen2) for AD; [LRRK2](/entities/lrrk2), [GBA](/entities/gba), SNCA for PD; [C9orf72](/entities/c9orf72), SOD1, FUS for ALS
Polygenic risk scores: Aggregate risk from multiple variants

Digital Biomarkers

Wearable and digital technologies enable continuous monitoring:

Motion sensors: Detect tremor, bradykinesia, gait abnormalities
Voice analysis: Identify speech patterns in PD and AD
Sleep tracking: Detect REM sleep behavior disorder
Cognitive games: Monitor subtle cognitive changes

Disease-Specific Diagnostic Approaches

Alzheimer's Disease

Clinical evaluation with cognitive testing

MRI to assess atrophy and rule out other causes

Amyloid PET or CSF biomarkers for amyloid confirmation

Tau PET or CSF phosphorylated tau for tau pathology

FDG-PET for hypometabolism pattern

Parkinson's Disease

Clinical diagnosis based on UK MDS criteria

DaT-SPECT to confirm dopaminergic deficit

Smell identification test (UPSIT) for prodromal detection

MRI to rule out atypical parkinsonism

Sleep study for REM behavior disorder

Amyotrophic Lateral Sclerosis

Clinical evaluation of upper and lower motor neuron signs

EMG and nerve conduction studies

MRI to rule out structural lesions

Genetic testing (especially for familial ALS)

Neurofilament biomarkers for prognosis

Future Directions

The field is moving toward:

Blood-based biomarkers: Less invasive than CSF, suitable for screening
Multimodal algorithms: Combine multiple biomarkers for accuracy
Digital health integration: Continuous monitoring in natural settings
Early detection: Identifying prodromal stages for preventive intervention

External Links

[PubMed](https://pubmed.ncbi.nlm.nih.gov/)
[KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Topics

[Diagnostics Overview](/diagnostics/overview) — This page
[Diagnostics Rankings](/diagnostics/rankings) — Ranked list by research activity
[Diagnostics Dashboard](/diagnostics/dashboard) — Data visualizations and metrics

Summary Statistics

Total Pages: 25 Diagnostics pages in this section
Last Updated: This section is actively maintained

A-Z All Pages

[APOE Genotyping for Neurodegenerative Disease Risk Assessment](/diagnostics/apoe-genotyping)
[Automated Imaging Differentiation for Parkinsonism (AIDP)](/diagnostics/automated-imaging-differentiation-parkinsonism)
[Alpha-Synuclein RT-QuIC Assay](/diagnostics/alpha-synuclein-rt-quic)
[Alpha-Synuclein Seeding Assays](/diagnostics/alpha-synuclein-seeding-assay)
[Alpha-Synuclein Seeding Assays](/diagnostics/alpha-synuclein-seeding-assays)
[Biomarker Types Overview](/diagnostics/biomarker-overview)
[Cerebrospinal Fluid (CSF) Biomarkers in Neurodegeneration](/diagnostics/csf-biomarkers)
[Clinical Assessment Scales for Neurodegenerative Diseases](/diagnostics/clinical-assessment-scales)
[Cognitive Assessment Tools for Neurodegenerative Diseases](/diagnostics/cognitive-assessments)
[Diagnostic Accuracy Rankings](/diagnostics/accuracy-rankings)
[Diagnostics Rankings](/diagnostics/rankings)
[Diffusion Tensor Imaging in Neurodegeneration](/diagnostics/diffusion-tensor-imaging-neurodegeneration)
[Digital Biomarkers for Neurodegeneration](/diagnostics/digital-biomarkers)
[Electroencephalography in Neurodegeneration](/diagnostics/electroencephalography)
[Electromyography and Nerve Conduction Studies](/diagnostics/emg-nerve-conduction)
[Frontotemporal Dementia (FTD) Biomarkers](/diagnostics/ftd-biomarkers)
[Genetic Testing for Neurodegenerative Diseases](/diagnostics/genetic-testing)
[Montreal Cognitive Assessment (MoCA)](/diagnostics/montreal-cognitive-assessment)
[Multi-Analyte Biomarker Panels for Neurodegeneration](/diagnostics/fluid-biomarkers-panel)
[Neuroimaging in Neurodegenerative Diseases](/diagnostics/neuroimaging)
[Neuropathological Examination](/diagnostics/neuropathological-examination)
[Optical Coherence Tomography in Neurodegeneration](/diagnostics/optical-coherence-tomography)
[PET Imaging in Neurodegeneration](/diagnostics/pet-imaging)
[Plasma Biomarkers in Neurodegeneration](/diagnostics/plasma-biomarkers)
[Retinal Imaging in Neurodegeneration](/diagnostics/retinal-imaging)

[See all 25 diagnostics pages...](/diagnostics/rankings)

Coverage Gaps

Missing Disease-Specific Diagnostics Sections

These neurodegenerative diseases lack dedicated diagnostic method pages:

[Progressive Supranuclear Palsy (PSP)] — No diagnostic method page
[Corticobasal Syndrome (CBS)] — No diagnostic method page
[Multiple System Atrophy (MSA)] — Limited autonomic testing coverage
Huntington's Disease — Limited genetic testing/counseling content
[Dementia with Lewy Bodies (DLB)] — Missing sleep study/RBD content
[Frontotemporal Dementia (FTD)] — Limited biomarker content

Underdeveloped Diagnostic Categories

These diagnostic areas need expanded content:

Blood-based biomarkers — p-tau217, p-tau181,NfL expansion needed
Digital biomarkers — Limited wearable/continuous monitoring content
Retinal imaging — OCT for neurodegeneration underexplored
Genetic testing — Polygenic risk scores missing
AI-assisted diagnostics — Machine learning for imaging analysis (AIDP now available)

Thin Content Diagnostics Pages

These ranked diagnostic pages need expansion:

Optical Coherence Tomography in Neurodegeneration — Limited content
Retinal Imaging in Neurodegeneration — Needs expansion
Digital Biomarkers for Neurodegeneration — Needs more technologies

Actionable Tasks

To address these gaps, the following tasks are recommended:

~~Create PSP Diagnostic Methods page~~ (COMPLETED - via AIDP/ML page)

Expand DLB Diagnostic Methods (add RBD/sleep studies)

Expand Blood-based Biomarkers page (add p-tau217, p-tau181)

References

[Unknown, Biomarkers for neurodegenerative diseases (2023) (2023)](https://doi.org/10.1016/S1474-4422(23)

[Unknown, MoCA: A brief screening tool for mild cognitive impairment (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15954109/)

[Unknown, UPDRS: Unified Parkinson's Disease Rating Scale (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/11136110/)

[Unknown, Clinical Dementia Rating scale (1982) (1982)](https://pubmed.ncbi.nlm.nih.gov/8187591/)

[Unknown, Hippocampal atrophy in AD (2002) (2002)](https://pubmed.ncbi.nlm.nih.gov/11806130/)

[Unknown, DaT-SPECT in parkinsonism (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24366148/)

[Unknown, AT(N) classification framework (2018) (2018)](https://doi.org/10.1016/j.jalz.2018.02.013)

[Unknown, APOE and Alzheimer's risk (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/19968377/)

📖 View canonical wiki page →

Related Entities

diagnostics-overview

▸Metadataorigin_type: v1_polymorphic_backfill

slug	diagnostics-overview
kg_node_id	None
entity_type	diagnostic
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-86fe05f5f2e7
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'diagnostics-overview'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Diagnostics Overview

Diagnostic Methods Overview

Introduction

Diagnostic Modalities

Clinical Assessment

Diagnostic Methods Overview

Introduction

Diagnostic Modalities

Clinical Assessment

Neuroimaging

Fluid Biomarkers

Genetic Testing

Digital Biomarkers

Disease-Specific Diagnostic Approaches

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Future Directions

See Also

External Links

Topics

Summary Statistics

A-Z All Pages

Coverage Gaps

Missing Disease-Specific Diagnostics Sections

Underdeveloped Diagnostic Categories

Thin Content Diagnostics Pages

Actionable Tasks

References

💬 Discussion

📗 Cite This Artifact

Diagnostics Overview

Diagnostic Methods Overview

Introduction

Diagnostic Modalities

Clinical Assessment

Diagnostic Methods Overview

Introduction

Diagnostic Modalities

Clinical Assessment

Neuroimaging

Fluid Biomarkers

Genetic Testing

Digital Biomarkers

Disease-Specific Diagnostic Approaches

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Future Directions

See Also

Related Index Pages

External Links

Topics

Summary Statistics

A-Z All Pages

Coverage Gaps

Missing Disease-Specific Diagnostics Sections

Underdeveloped Diagnostic Categories

Thin Content Diagnostics Pages

Actionable Tasks

References

💬 Discussion